Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |